// App-Quantinova.ai

423 : Low Molecular Weight Heparin (LMWH) Prophylaxis to Prevent Sinusoidal Obstructive Syndrome (SOS) in Pediatric Hematopoietic Stem Cell Transplant (HSCT) Recipients

Researchers

Presenter

  • Zelda Ghersin

Principal Investigators

  • Lauren Harrison

  • Debra Abrams

  • Harshini Mahanti

  • Sandra Fabricatore

  • Liana Klejmont

  • Olga Militano

  • Carmella vande Ven

  • Mitchell S. Cairo

Medical Centers

  • New York Medical College, Valhalla, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Acute lymphoblastic leukemia

  • Sickle cell anemia

  • Hepatic fibrosis

  • Rhabdoid predisposition syndrome

  • Venous thrombosis

Biomarkers

  • Breakpoint Cluster Region

  • Soluble Complement 5b-9

Drug/Treatment

  • Heparin

  • Busulfan

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved